tiprankstipranks
IGC Pharma (IGC)
XASE:IGC
US Market
IGC
IGC Pharma
RESEARCH TOOLSreports
Want to see IGC full AI Analyst Report?

IGC Pharma (IGC) Ratios

1,036 Followers

IGC Pharma Ratios

IGC's free cash flow for Q4 2026 was $0.17. For the 2026 fiscal year, IGC's free cash flow was decreased by $ and operating cash flow was $-7.58. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Jun 23
Liquidity Ratios
Current Ratio
 0.40 0.40 1.28 1.58 3.41
Quick Ratio
 0.17 0.18 0.68 0.91 2.01
Cash Ratio
 0.07 0.07 0.18 0.51 1.68
Solvency Ratio
 -2.01 -2.03 -2.75 -4.79 -4.79
Operating Cash Flow Ratio
 -2.07 -2.07 -2.12 -2.22 -3.71
Short-Term Operating Cash Flow Coverage
 -8.19 -8.19 0.00 -40.94 0.00
Net Current Asset Value
$ -1.92M$ -1.92M$ 479.00K$ 1.12M$ 4.20M
Leverage Ratios
Debt-to-Assets Ratio
 0.10 0.10 0.03 0.04 0.03
Debt-to-Equity Ratio
 0.15 0.15 0.04 0.05 0.03
Debt-to-Capital Ratio
 0.13 0.13 0.04 0.05 0.03
Long-Term Debt-to-Capital Ratio
 0.03 0.03 0.02 0.02 <0.01
Financial Leverage Ratio
 1.50 1.50 1.38 1.35 1.15
Debt Service Coverage Ratio
 -8.49 -8.57 0.00 -72.13 0.00
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
 0.03 0.04 <0.01 <0.01 <0.01
Interest Debt Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Net Debt to EBITDA
 -0.12 -0.12 0.03 0.09 0.25
Profitability Margins
Gross Profit Margin
29.68%29.68%48.70%54.50%-17.34%
EBIT Margin
-552.11%-552.11%-560.27%-728.48%-1263.01%
EBITDA Margin
-519.90%-524.79%-523.76%-681.12%-1190.89%
Operating Profit Margin
-860.29%-860.29%-585.84%-728.48%-1270.14%
Pretax Profit Margin
-552.11%-552.11%-560.27%-966.54%-1263.01%
Net Profit Margin
-552.11%-552.11%-560.27%-966.54%-1263.01%
Continuous Operations Profit Margin
-552.11%-552.11%-560.27%-966.54%-1263.01%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
64.18%64.18%95.64%132.68%99.44%
Return on Assets (ROA)
-71.29%-71.29%-81.41%-131.29%-66.98%
Return on Equity (ROE)
-94.51%-106.98%-112.50%-177.57%-77.16%
Return on Capital Employed (ROCE)
-161.64%-161.64%-114.73%-129.57%-75.73%
Return on Invested Capital (ROIC)
-144.79%-144.79%-113.09%-127.43%-75.07%
Return on Tangible Assets
-167.17%-167.17%-103.28%-156.89%-71.88%
Earnings Yield
-24.99%-26.20%-32.65%-46.42%-64.46%
Efficiency Ratios
Receivables Turnover
 32.05 32.05 16.51 34.49 8.51
Payables Turnover
 0.66 0.66 0.74 0.79 2.02
Inventory Turnover
 1.27 1.31 0.48 0.39 0.40
Fixed Asset Turnover
 0.56 0.56 0.38 0.35 0.11
Asset Turnover
 0.13 0.13 0.15 0.14 0.05
Working Capital Turnover Ratio
 -1.13 -2.18 1.27 0.45 0.11
Cash Conversion Cycle
 -258.64 -258.64 289.14 492.48 767.07
Days of Sales Outstanding
 11.39 11.39 22.11 10.58 42.87
Days of Inventory Outstanding
 279.22 279.22 761.35 942.92 905.16
Days of Payables Outstanding
 549.25 549.25 494.32 461.02 180.96
Operating Cycle
 290.61 290.61 783.46 953.50 948.03
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.06 -0.06 -0.06 -0.09 -0.13
Free Cash Flow Per Share
 -0.07 -0.06 -0.07 -0.10 -0.15
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01 0.01
Free Cash Flow to Operating Cash Flow
 1.06 1.03 1.10 1.10 1.09
Dividend Paid and CapEx Coverage Ratio
 -17.85 -36.24 -9.95 -10.10 -11.38
Capital Expenditure Coverage Ratio
 -17.85 -36.24 -9.95 -10.10 -11.38
Operating Cash Flow Coverage Ratio
 -6.42 -6.42 -20.15 -14.94 -14.65
Operating Cash Flow to Sales Ratio
 -5.01 -5.01 -3.77 -3.87 -7.74
Free Cash Flow Yield
-22.74%-24.43%-24.20%-20.40%-42.95%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -3.89 -3.64 -3.06 -2.15 -1.55
Price-to-Sales (P/S) Ratio
 23.71 21.08 17.16 20.82 19.59
Price-to-Book (P/B) Ratio
 4.36 4.08 3.45 3.83 1.20
Price-to-Free Cash Flow (P/FCF) Ratio
 -4.48 -4.09 -4.13 -4.90 -2.33
Price-to-Operating Cash Flow Ratio
 -4.49 -4.21 -4.55 -5.39 -2.53
Price-to-Earnings Growth (PEG) Ratio
 -0.20 0.16 0.05 0.00 0.06
Price-to-Fair Value
 4.36 4.08 3.45 3.83 1.20
Enterprise Value Multiple
 -4.68 -4.13 -3.25 -2.96 -1.40
Enterprise Value
 28.31M 25.71M 21.64M 27.16M 15.13M
EV to EBITDA
 -4.55 -4.13 -3.25 -2.96 -1.40
EV to Sales
 23.87 21.68 17.03 20.19 16.61
EV to Free Cash Flow
 -4.51 -4.21 -4.10 -4.75 -1.97
EV to Operating Cash Flow
 -4.76 -4.33 -4.51 -5.22 -2.15
Tangible Book Value Per Share
 <0.01 <0.01 0.06 0.10 0.26
Shareholders’ Equity Per Share
 0.06 0.06 0.08 0.12 0.28
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 0.01 0.01 0.02 0.02 0.02
Net Income Per Share
 -0.07 -0.07 -0.09 -0.22 -0.22
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 1.00 1.00 1.00 1.33 1.00
Research & Development to Revenue
 4.38 4.38 2.88 2.81 3.80
SG&A to Revenue
 4.52 4.52 3.47 0.00 0.00
Stock-Based Compensation to Revenue
 2.01 0.38 1.29 1.32 3.12
Income Quality
 0.91 0.91 0.67 0.40 0.61
Currency in USD